User contributions
- 23:43, 27 April 2024 (diff | hist) . . (+3,695) . . N Olssonosborn1881 (Created page with "2% and also Forty-one.3% regarding people in the ravulizumab provide as well as eculizumab equip, correspondingly, achieved almost all blend endpoint aspect thresholds (treatm...") (current)